GALMED PHARMACEUTICALS LTD. (GLMD) Operating cash flow 2016–2025
GALMED PHARMACEUTICALS LTD. (GLMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.3MFY2025 · since FY2016: -$12.1M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -7.4% |
| FY2024 | -$5.9M | +4.2% |
| FY2023 | -$6.1M | +66.8% |
| FY2022 | -$18.5M | +43.8% |
| FY2021 | -$32.9M | -25.1% |
| FY2020 | -$26.3M | -76.0% |
| FY2019 | -$14.9M | -65.5% |
| FY2018 | -$9.0M | +25.2% |
| FY2017 | -$12.1M | +0.5% |
| FY2016 | -$12.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice